Pancreatic Cancer Research

ResearcherFirst Hospital of Lanzhou UniversityNo recent work listed

Hao Ming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7856-2535; OpenAlex author ID A5015354561. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers

Papers 3

  1. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. First author DOI 10.1002/jcla.24381↗
  2. Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations. Co-author DOI 10.3389/fimmu.2022.844401↗
  3. LncRNA SNHG16 Contributes to Tumor Progression via miR-302b-3p/SLC2A4 in Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-64744/v1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wence Zhou · 3 shared papers, 2020–2022 · strength 0.54
  2. Changpeng Chai · 1 shared paper, 2022 · strength 0.20
  3. Huaqing Shi · 1 shared paper, 2022 · strength 0.20
  4. Zhou Chen · 1 shared paper, 2022 · strength 0.20
  5. Shi Dong · 1 shared paper, 2022 · strength 0.20
  6. Bo Zhang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.